Literature DB >> 3195475

Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the Coronary Artery Surgery Study (CASS) registry.

D A Weiner1, T J Ryan, C H McCabe, G Ng, B R Chaitman, L T Sheffield, F E Tristani, L D Fisher.   

Abstract

To evaluate whether patients with silent myocardial ischemia during exercise testing are at increased risk for developing a subsequent acute myocardial infarction or sudden death, the data on 424 such patients with proven coronary artery disease (CAD) from the Coronary Artery Surgery Study (CASS) registry were analyzed. These patients (group 1) were compared with 456 other patients with CAD (group 2) who had both ischemic ST depression and angina pectoris during exercise testing and with 1,019 control patients without CAD. The probability of remaining free of a subsequent acute myocardial infarction or sudden death at 7 years was 80 and 91%, respectively, for group 1, 82 and 93%, respectively, for group 2 (difference not significant, compared with group 1), and 98 and 99%, respectively, for the control patients (p less than 0.001), compared with group 1 or 2). Among patients in group 1, the probability of remaining free of myocardial infarction and sudden death at 7 years was related to the severity of CAD and presence of left ventricular (LV) dysfunction, and ranged from 90% for patients with 1-vessel CAD and preserved LV function to 38% for patients with 3-vessel CAD and abnormal LV function (p less than 0.001). Thus, patients with either silent or symptomatic ischemia during exercise testing have a similar risk of developing an acute myocardial infarction or sudden death--except in the 3-vessel CAD subgroup, where the risk is greater in silent ischemia. The risk of patients with silent myocardial ischemia is based primarily on angiographic variables.

Entities:  

Mesh:

Year:  1988        PMID: 3195475     DOI: 10.1016/0002-9149(88)90251-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 2.  [Significance of silent myocardial ischemia for identification and optimal therapy of patients with latent coronary heart disease. Is there a marker for prognostic indication for PTCA?].

Authors:  D Hering; H P Schultheiss; D Horstkotte
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

Review 3.  Silent ischaemia in the 1990s.

Authors:  D Tzivoni
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis.

Authors:  J Lette; D Waters; J Lassonde; S Dubé; F Heyen; M Picard; M Morin
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

Review 5.  Gender in cardiovascular medicine: chest pain and coronary artery disease.

Authors:  Puja K Mehta; Courtney Bess; Suzette Elias-Smale; Viola Vaccarino; Arshed Quyyumi; Carl J Pepine; C Noel Bairey Merz
Journal:  Eur Heart J       Date:  2019-12-14       Impact factor: 29.983

6.  Ambulatory and silent myocardial ischemia in women with coronary microvascular dysfunction: Results from the Cardiac Autonomic Nervous System study (CANS).

Authors:  Rajasree Roy; Haider Aldiwani; Navid Darouian; Shilpa Sharma; Tina Torbati; Janet Wei; Michael D Nelson; Chrisandra Shufelt; Margo B Minissian; Lian Li; C Noel Bairey Merz; Puja K Mehta
Journal:  Int J Cardiol       Date:  2020-04-19       Impact factor: 4.039

Review 7.  Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?

Authors:  Pupalan Iyngkaran; William Chan; Danny Liew; Jalal Zamani; John D Horowitz; Michael Jelinek; David L Hare; James A Shaw
Journal:  World J Methodol       Date:  2019-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.